Urotronic Inc. is an early stage medical device company developing drug/device combination products. Our mission is to develop revolutionary technologies that will transform the urology market through better patient outcomes that are uniquely positioned for today''s healthcare environment.
An exciting innovation in urology, Urotronic’s Drug Coated Balloon — Optilume for Stricture —was inspired by severe patient and physician dissatisfaction with current urethral stricture solutions. This proprietary technology combines balloon dilation and drug delivery. Rapid uptake of the highly lipophilic drug, paclitaxel, limits hyperactive cell proliferation and the fibrotic scar tissue generation that results in stricture recurrence. 24 month data has demonstrated a 71% reduction in IPSS and a 290% increase in Qmax in a patient population of men with two or more prior endoscopic treatments.
Urotronic has just finished enrollment of stricture patients in its pivotal US clinical trial.
Optilume BPH is currently enrolling patients in its pivotal US clinical trial.
Please visit us at booth 527 at the AUA or at www.urotronic.com for more information.
Brands: Optilume drug-coated urology balloon for BPH and urethral strictures